Since endostatin can be secreted by both normal endothelium cells and tumor cells, increased serum levels of endostatin in GC patients can be explained by the hypothesis that endostatin is generated by a negative feedback mechanism in an attempt to repress or offset the upregulated angiogenesis in tumors [39]. Here, COL18A1 is linked to neoplasm.